Cargando…

Controlled human malaria infection in Kenyan adults: A safe model that could accelerate assessment of novel drugs and vaccines in malaria endemic populations

Detalles Bibliográficos
Autores principales:	Hodgson, Susanne, Juma, Elizabeth, Salim, Amina, Magiri, Charles, Kimani, Domtila, Njenga, Daniel, Muia, Alfred, Cole, Andrew, Ogwang, Caroline, Billingsley, Peter, James, Eric, Sim, Kim Lee, Rampling, Thomas, Hill, Adrian, Osier, Faith, Draper, Simon, Bejon, Philip, Hoffman, Stephen, Ogutu, Bernhards, Marsh, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179251/ http://dx.doi.org/10.1186/1475-2875-13-S1-O33

Ejemplares similares

Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection
por: Hodgson, Susanne H., et al.
Publicado: (2014)

Plasmodium falciparum malaria parasite var gene expression is modified by host antibodies: longitudinal evidence from controlled infections of Kenyan adults with varying natural exposure
por: Abdi, Abdirahman I., et al.
Publicado: (2017)

Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya
por: Hodgson, Susanne H, et al.
Publicado: (2015)

Changes in Serological Immunology Measures in UK and Kenyan Adults Post-controlled Human Malaria Infection
por: Hodgson, Susanne H., et al.
Publicado: (2016)

Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studies
por: Hodgson, Susanne H, et al.
Publicado: (2015)

Safety and PCR monitoring in 161 semi-immune Kenyan adults following controlled human malaria infection
por: Kapulu, Melissa C., et al.
Publicado: (2021)

Controlled human malaria infection (CHMI) outcomes in Kenyan adults is associated with prior history of malaria exposure and anti-schizont antibody response
por: Kapulu, Melissa C., et al.
Publicado: (2022)

The Ratio of Monocytes to Lymphocytes in Peripheral Blood Correlates with Increased Susceptibility to Clinical Malaria in Kenyan Children
por: Warimwe, George M., et al.
Publicado: (2013)

Targets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children
por: Murungi, Linda M., et al.
Publicado: (2016)

What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity
por: Kinyanjui, Samson M, et al.
Publicado: (2009)

Efficacy of 3-day low dose quinine plus clindamycin versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children (CLINDAQUINE): an open-label randomized trial
por: Obonyo, Charles O., et al.
Publicado: (2022)

Decorticate, decerebrate and opisthotonic posturing and seizures in Kenyan children with cerebral malaria
por: Idro, Richard, et al.
Publicado: (2005)

Malaria management - progress made and challenges still to face
por: Ogutu, Bernhards R
Publicado: (2009)

Acute seizures attributable to falciparum malaria in an endemic area on the Kenyan coast
por: Kariuki, Symon M., et al.
Publicado: (2011)

Deliberately infecting healthy volunteers with malaria parasites: Perceptions and experiences of participants and other stakeholders in a Kenyan‐based malaria infection study
por: Jao, Irene, et al.
Publicado: (2020)

Lack of Avidity Maturation of Merozoite Antigen-Specific Antibodies with Increasing Exposure to Plasmodium falciparum amongst Children and Adults Exposed to Endemic Malaria in Kenya
por: Ibison, Frances, et al.
Publicado: (2012)

Understanding the benefits and burdens associated with a malaria human infection study in Kenya: experiences of study volunteers and other stakeholders
por: Chi, Primus Che, et al.
Publicado: (2021)

Malaria hotspots defined by clinical malaria, asymptomatic carriage, PCR and vector numbers in a low transmission area on the Kenyan Coast
por: Kangoye, David Tiga, et al.
Publicado: (2016)

A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria()
por: Murungi, Linda M., et al.
Publicado: (2013)

Clearance of Asymptomatic P. falciparum Infections Interacts with the Number of Clones to Predict the Risk of Subsequent Malaria in Kenyan Children
por: Liljander, Anne, et al.
Publicado: (2011)

Long-lasting insecticide-treated net use and malaria infections on the Kenyan coast
por: Kamau, Alice, et al.
Publicado: (2022)

Malaria vaccine roller coaster
por: Nkumama, Irene N., et al.
Publicado: (2021)

Stable and Unstable Malaria Hotspots in Longitudinal Cohort Studies in Kenya
por: Bejon, Philip, et al.
Publicado: (2010)

Controlled human malaria infections using aseptic, purified cryopreserved Plasmodium falciparum sporozoites administered by needle and syringe
por: Billingsley, Peter, et al.
Publicado: (2014)

A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya
por: Juma, Elizabeth A, et al.
Publicado: (2008)

Correction: Stable and Unstable Malaria Hotspots in Longitudinal Cohort Studies in Kenya
por: Bejon, Philip, et al.
Publicado: (2011)

FEEDBACK OF RESEARCH FINDINGS FOR VACCINE TRIALS: EXPERIENCES FROM TWO MALARIA VACCINE TRIALS INVOLVING HEALTHY CHILDREN ON THE KENYAN COAST
por: Gikonyo, Caroline, et al.
Publicado: (2013)

Comparison of allele frequencies of Plasmodium falciparum merozoite antigens in malaria infections sampled in different years in a Kenyan population
por: Ochola-Oyier, Lynette Isabella, et al.
Publicado: (2016)

A Statistical Interaction between Circumsporozoite Protein-Specific T Cell and Antibody Responses and Risk of Clinical Malaria Episodes following Vaccination with RTS,S/AS01E
por: Ndungu, Francis M., et al.
Publicado: (2012)

Spatial–temporal clustering of malaria using routinely collected health facility data on the Kenyan Coast
por: Kamau, Alice, et al.
Publicado: (2021)

Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S/AS01(E) and Protection against P falciparum Clinical Malaria
por: Olotu, Ally, et al.
Publicado: (2011)

Readiness of the Kenyan public health sector to provide pre‐referral care for severe paediatric malaria
por: Amboko, Beatrice, et al.
Publicado: (2022)

Quinine plus clindamycin vs artemether-lumefantrine for treatment of uncomplicated falciparum malaria in western Kenya
por: Obonyo, Charles O., et al.
Publicado: (2022)

Sample-ready multiplex qPCR assay for detection of malaria
por: Kamau, Edwin, et al.
Publicado: (2014)

Changing Malaria Prevalence on the Kenyan Coast since 1974: Climate, Drugs and Vector Control
por: Snow, Robert W., et al.
Publicado: (2015)

CD4(+) T Cell Responses to the Plasmodium falciparum Erythrocyte Membrane Protein 1 in Children with Mild Malaria
por: Gitau, Evelyn N., et al.
Publicado: (2014)

Impact of Intermittent Presumptive Treatment for Malaria in Pregnancy on Hospital Birth Outcomes on the Kenyan Coast
por: Kamau, Alice, et al.
Publicado: (2022)

Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in Healthy Gambian and Kenyan Adults
por: Ogwang, Caroline, et al.
Publicado: (2013)

Prevalence of malaria parasites in adults and its determinants in malaria endemic area of Kisumu County, Kenya
por: Jenkins, Rachel, et al.
Publicado: (2015)

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01 (E) on blood stage immunity in young Kenyan children
por: Ndungu, Francis M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vt5has27bcio9k7uui6ad0kg0b